A Personal History of Cystinosis by Dr. Jerry Schneider
- PMID: 35326395
- PMCID: PMC8945924
- DOI: 10.3390/cells11060945
A Personal History of Cystinosis by Dr. Jerry Schneider
Abstract
Cystinosis is a rare lysosomal storage disease that is tightly linked with the name of the American physician and scientist Dr. Jerry Schneider. Dr. Schneider (1937-2021) received his medical degree from Northwestern University, followed by a pediatrics residency at Johns Hopkins University and a fellowship in inherited disorders of metabolism. He started to work on cystinosis in J. Seegmiller's laboratory at the National Institutes of Health (NIH) and subsequently moved to the UC San Diego School of Medicine, where he devoted his entire career to people suffering from this devastating lysosomal storage disorder. In 1967, Dr. Schneider's seminal Science paper 'Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis' opened a new era of research towards understanding the pathogenesis and finding treatments for cystinosis patients. His tremendous contribution transformed cystinosis from a fatal disorder of childhood to a treatable chronic disease, with a new generation of cystinosis patients being now in their 40th and 50th years. Dr. Schneider wrote a fascinating 'Personal History of Cystinosis' highlighting the major milestones of cystinosis research. Unfortunately, he passed away before this manuscript could be published. Fifty-five years after his first paper on cystinosis, the 'Personal History of Cystinosis' by Dr. Schneider is a tribute to his pioneering discoveries in the field and an inspiration for young doctors and scientists who have taken over the torch of cystinosis research towards finding a cure for cystinosis.
Keywords: cystinosis; history; lysosomal storage disorder; treatment strategies for cystinosis.
Conflict of interest statement
J. Schneider was a consultant for Raptor Pharmaceutical Company, the manufacturer of the new form of cysteamine. E. Levtchenko performs consultancy for Recordati, Chiesi, Kyowa Kirin and Advicenne and was supported by a research grant of Horizon Pharma.
Figures



Similar articles
-
Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. doi: 10.1967/s002449910713. Epub 2018 Mar 20. Hell J Nucl Med. 2018. PMID: 29550853
-
Lysosomal cystine counter-transport in heterozygotes for cystinosis.Am J Hum Genet. 1984 Mar;36(2):277-82. Am J Hum Genet. 1984. PMID: 6711558 Free PMC article.
-
Special issue dedicated in memory of Dr. Edward H. Ahrens, Jr.Cardiovasc Drug Rev. 2002 Winter;20(4):237-343. Cardiovasc Drug Rev. 2002. PMID: 12481196
-
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.Mol Genet Metab. 2000 Sep-Oct;71(1-2):100-20. doi: 10.1006/mgme.2000.3062. Mol Genet Metab. 2000. PMID: 11001803 Review.
-
Recent progress in our knowledge of cystinosis.Clin Endocrinol Metab. 1974 Mar;3(1):57-69. doi: 10.1016/s0300-595x(74)80025-3. Clin Endocrinol Metab. 1974. PMID: 4609649 Review. No abstract available.
Cited by
-
Emerging therapeutic strategies for cystinosis.Front Pediatr. 2025 May 21;13:1601409. doi: 10.3389/fped.2025.1601409. eCollection 2025. Front Pediatr. 2025. PMID: 40469087 Free PMC article. Review.
References
Publication types
MeSH terms
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources